In vivo action of a new octadecaneuropeptide (ODN) antagonist on gonadotropin-releasing hormone gene expression in the male rat brain

Neuroscience

Volumn 125, Issue 2, 2004, Pages 411-415

  Compere V ^a   Li, S ^b   Leprince, J ^a   Tonon, M C ^a   Vaudry, H ^a   Pelletier, G ^b  

^a UNIVERSITÉ DE ROUEN   (France)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

aminobutyric acid; ANT; Antagonist; Benzodiazepine; BZD; Cyclo1 8 Dleu5 OP; DBI; Diazepam binding inhibitor; GABA; GnRH; Gonadotropin releasing hormone; Metabotropic receptor; MPAO; Octadecaneuropeptide

Indexed keywords

CYCLIC ARGINYLPROLYLGLYCYLLEUCYL DEXTRO LEUCYLASPARTYLLEUCYLLYSINE; GONADORELIN; MESSENGER RNA; METABOTROPIC RECEPTOR ANTAGONIST; OCTADECANEUROPEPTIDE; OCTADECANEUROPEPTIDE ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; GENE EXPRESSION REGULATION; HORMONAL REGULATION; IN SITU HYBRIDIZATION; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; CASTRATION; DIAZEPAM BINDING INHIBITOR; DRUG INTERACTIONS; GENE EXPRESSION; GONADOTROPIN-RELEASING HORMONE; IN SITU HYBRIDIZATION; MALE; NEUROPEPTIDES; PEPTIDE FRAGMENTS; PEPTIDES, CYCLIC; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 18744429217     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2004.02.016     Document Type: Article

References (21)

1. Compère V., Li S., Leprince J., Tonon M.C., Vaudry H., Pelletier G. Effect of intracerebroventricular administration of the octadecaneuropeptide on the expression of pro-opiomelanocortin, neuropeptide y and corticotropin-releasing hormone mRNAs in rat hypothalamus. J Neuroendocrinol. 15:2003;197-203.
2. De Mateos-Verchere J.G., Leprince J., Tonon M.C., Vaudry H., Costentin J. The octadecaneuropeptide [diazepam-inhibitor (33-50)] exerts potent anorexigenic effects in rodents. Eur J Pharmacol. 414:2001;225-231.
3. Ferrero P., Santi M.R., Conti-Tronconi B., Costa E., Guidotti A. Study of an octadecaneuropeptide derived from diazepam binding inhibitor (DBI) Biological activity and presence in rat brain. Proc Natl Acad Sci USA. 83:1986;827-831.
4. Fuchs E., Mansky T., Stock K.W., Vijayan E., Wuttke W. Involvement of catecholamines and glutamate in GABAergic mechanism regulatory to luteinizing hormone and prolactin secretion. Neuroendocrinology. 38:1984;484-489.
5. 2+ in rat astrocytes is not mediated through classical benzodiazepine receptors. Eur J Pharmacol. 322:1997;275-281.
6. Guidotti A., Forchetti C.M., Corda M.G., Kondel D., Bennett C.D., Costa E. Isolation, characterization and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors. Proc Natl Acad Sci USA. 80:1983;3531-3533.
7. Kalra S.P. Neural circuitry involved in the control of LHRH secretion A model for preovilatory lh release. Front Neuroendocrinol. 9:1986;31-35.
8. Leprince J., Gandolfo P., Thoumas J.L., Patte C., Fauchere J.L., Vaudry H., Tonon M.C. Structure-activity relationships of a series of analogues or the octadecaneuropeptide ODN on calcium mobilization in rat astrocytes. J Med Chem. 41:1998;4433-4438.
9. Leprince J., Oulyadi H., Vaudry D., Masmoudi O., Gandolfo P., Patte C., Costentin J., Fauchere J.L., Davoust D., Vaudry H., Tonon M.C. Synthesis, conformational analysis and biological activity of cyclic analogs of the octadecaneuropeptide ODN Design of a potent endozepine antagonist. Eur J Biochem. 268:2001;6045-6057.
10. Li S., Pelletier G. Chronic administration of muscimol and pentobarbital decreases gonadotropin-releasing hormone mRNA levels in the male rat hypothalamus determined by quantitative in situ hybridization. Neuroendocrinology. 58:1993;136-139.
11. e Colloque de la Société de Neuroendocrinologie Expérimentale Ann Endocrinol, Magog-Oxford (Québec):414 (abs. P37).
12. Li S., Pelletier G. Inhibitory effect of the endogenous benzodiazepine receptor ligand, octadecaneuropeptide (ODN), on gonadotropin-releasing hormone gene expression in the male rat brain. Neuroreport. 6:1995;1354-1356.
13. Li S., Pelletier G. Further studies on the mechanism of action of the endogenous benzodiazepine ligand octadecaneuropeptide (ODN) on gonadotropin-releasing hormone gene expression in rat brain. Neuroendocrinology. 64:1996;79-84.
14. Li S., Givalois L., Pelletier G. Role of adrenal an gonadal steroids in the response of GnRH gene expression to the endogenous benzodiazepine receptor ligand octadecaneuropeptide in the male rat brain. Neuropeptides. 31:1997;463-468.
15. Meller W.H., Grambsch P.L., Bingham C., Tagatz G.E. Hypothalamic pituitary gonadal axis dysregulation in depressed women. Psychoneuroendocrinology. 26:2001;253-259.
16. Orta, MH, Do Rego, JC, Leprince, J, Vaudry, H, Costentin, J (2003) Effets de l'octadecaneuropeptide (ODN) sur la prise alimentaire: caractérisation du récepteur impliqué. 6e colloque de la Société des neurosciences I-51.
17. Patte C., Vaudry H., Desrue L., Gandolpho P., Strijveen I., Lamacz M., Tonon M.C. The endozepine ODN stimulates polyphosphoinositide metabolism in rat astrocyte. FESB Lett. 362:1995;106-110.
18. Roy A. Cerebrospinal fluid diazepam binding inhibitor in depressed patients and normal controls. Neuropharmacology. 30:1991;1441-1444.
19. Slobodyansky E., Guidotti A., Wambebe C., Berkovich A., Costa E. Isolation and characterization of a rat brain triakontatetraneuropeptide, a posttranslational product of diazepam binding inhibitor Specific action at the ro5-4864 recognition site. J Neurochem. 53:1989;1276-1284.
20. Toranzo D., Dupont E., Simard J., Labrie C., Couet J., Labrie F., Pelletier G. Regulation of pro-gonadotropin-releasing hormone gene expression by sex steroids in the brain of male and female rats. Mol Endocrinol. 3:1989;1748-1756.
21. Vincens M., Li S., Pelletier G. Inhibitory effect of 5β-pregnan- 3α-ol-1 on gonadotropin-releasing hormone gene expression in the male rat. Eur J Pharmacol. 260:1994;157-162.